Dopamine in substantia nigra and cortex after gamma-butyrolactone treatment

J Pharm Pharmacol. 1976 Jun;28(6):527-30. doi: 10.1111/j.2042-7158.1976.tb02784.x.
No abstract available

MeSH terms

  • 4-Butyrolactone / pharmacology*
  • Animals
  • Caudate Nucleus / drug effects
  • Caudate Nucleus / metabolism
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism*
  • Dopamine / metabolism*
  • Furans / pharmacology*
  • Male
  • Nerve Endings / metabolism
  • Norepinephrine / metabolism
  • Rats
  • Substantia Nigra / drug effects
  • Substantia Nigra / metabolism*

Substances

  • Furans
  • 4-Butyrolactone
  • Dopamine
  • Norepinephrine